Inventor · disambiguated record
Darren B. Dressen
Also filed as: DRESSEN DARREN · DRESSEN DARREN B · DRESSEN DARREN D
35 granted patents·9 pending applications·503 citations·filing 1998–2010
98Inventor score
Top patents by PatentIndex Score
44 records- 0198US7049306B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.ELAN PHARM INC·Filed 2002·Granted May 23, 2006·90 cites·6 claims
- 0295US6407066B1Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Jun 18, 2002·52 cites·16 claims
- 0393US6794506B23-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Sep 21, 2004·30 cites·22 claims
- 0492US7005433B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2003·Granted Feb 28, 2006·27 cites·9 claims
- 0591US7101855B2Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Sep 5, 2006·21 cites·17 claims
- 0688US6689781B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2001·Granted Feb 10, 2004·27 cites·9 claims
- 0787US6900179B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2001·Granted May 31, 2005·16 cites·13 claims
- 0886US7229970B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2005·Granted Jun 12, 2007·2 cites·11 claims
- 0986US6586602B2Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2002·Granted Jul 1, 2003·10 cites·13 claims
- 1085US7973044B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Jul 5, 2011·4 cites·19 claims
- 1184US6492421B1Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Dec 10, 2002·52 cites·35 claims
- 1283US7320960B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2002·Granted Jan 22, 2008·5 cites·20 claims
- 1383US6525026B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Feb 25, 2003·9 cites·18 claims
- 1481US7968547B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Jun 28, 2011·2 cites·10 claims
- 1581US6489300B1Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 1998·Granted Dec 3, 2002·40 cites·22 claims
- 1680US7858642B2Substituted hydroxyethylamine aspartyl protease inhibitorsELAN PHARM INC·Filed 2009·Granted Dec 28, 2010·5 cites·24 claims
- 1780US7576101B2Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agentsELAN PHARM INC·Filed 2004·Granted Aug 18, 2009·13 cites·26 claims
- 1880US7288526B2Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Oct 30, 2007·5 cites·16 claims
- 1980US6953802B2Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2001·Granted Oct 11, 2005·13 cites·28 claims
- 2078US7291645B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2003·Granted Nov 6, 2007·7 cites·6 claims
- 2175US7417152B24-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B1 receptor antagonists for the treatment of inflammatory diseasesELAN PHARM INC·Filed 2004·Granted Aug 26, 2008·8 cites·11 claims
- 2275US7223762B2Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2005·Granted May 29, 2007·2 cites·17 claims
- 2375US7015216B2Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitorsWYETH CORP·Filed 2001·Granted Mar 21, 2006·8 cites·10 claims
- 2474US7166580B2Compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Jan 23, 2007·2 cites·11 claims
- 2571US6803370B2Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Oct 12, 2004·4 cites·13 claims
- 2670US7432379B2Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonistsELAN PHARM INC·Filed 2004·Granted Oct 7, 2008·5 cites·12 claims
- 2768US6423688B1Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Jul 23, 2002·16 cites·8 claims
- 2865US2008182850A13-(heteroaryl)alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4ELAN PHARM INC·Filed 2007·Application pending·0 cites
- 2963US7759382B2Acylated amino acid amidyl pyrazoles and related compoundsELAN PHARM INC·Filed 2004·Granted Jul 20, 2010·1 cites·10 claims
- 3063US6559127B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted May 6, 2003·12 cites·15 claims
- 3156US6362341B1Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Mar 26, 2002·7 cites·18 claims
- 3255US7745454B2Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2004·Granted Jun 29, 2010·0 cites·12 claims
- 3355US7365073B23-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2004·Granted Apr 29, 2008·0 cites·10 claims
- 3454US7030114B1Compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 1998·Granted Apr 18, 2006·8 cites·16 claims
- 3553US2006217362A1Novel compounds useful for bradykinin B1 receptor antagonismTUNG JAY S·Filed 2005·Application pending·0 cites
- 3651US8283358B2N-sulfonamido polycyclic pyrazolyl compoundsKONRADI ANDREI W·Filed 2009·Granted Oct 9, 2012·0 cites·24 claims
- 3751US2007123531A14-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseasesELAN PHARM INC·Filed 2004·Application pending·0 cites
- 3851US2007161633A14-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseasesELAN PHARM INC·Filed 2004·Application pending·0 cites
- 3950US7977368B2Pyrazolopyrrolidines as inhibitors of gamma secretaseELAN PHARM INC·Filed 2008·Granted Jul 12, 2011·0 cites·9 claims
- 4050US2005032868A1Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonistsFiled 2004·Application pending·0 cites
- 4150US2005038099A1Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonistsFiled 2004·Application pending·0 cites
- 4242US2010280066A1Acylated amino acid amidyl pyrazoles and related compoundsTUNG JAY S·Filed 2010·Application pending·0 cites
- 4342US2005239836A1Substituted hydroxyethylamine aspartyl protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
- 4437US2005261273A1Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitorsJOHN VARGHESE·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Darren B. Dressen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →